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In radiotherapy, the maximum dose used to cure a patient from a
tumour is partially limited by the occurrence of severe late normal
tissue reactions. The extent of these reactions varies individually
and shows a broad spectrum even after identical or comparable
schemes of irradiation (Bentzen and Overgaard, 1994; Turesson
et al, 1996).
There is now increasing evidence that the extent of late normal
tissue reactions may depend to a considerable extent on the
intrinsic cellular radiosensitivity (Geara et al, 1993; Bentzen 
and Overgaard, 1994; Ramsay and Birrell, 1995; Burnet et al,
1996; Johansen et al, 1996). So far, the factor(s) determining 
the intrinsic cellular radiosensitivity are not definitely known. 
For normal human fibroblasts, radiation-induced loss of cellular
reproductivity is known to result from chromosomal damage
(Cornforth and Bedford, 1987) and also from a permanent arrest 
at the G1/S border (Di Leonardo et al, 1994). Both of these 
effects appeared to be determined by non- or misrejoined DNA
double-strand breaks (dsbs). This was recently observed in our
laboratory for a variety of normal human fibroblasts (Dikomey et
al, 1999), where a good correlation between the cellular radiosen-
sitivity and the number of non-repaired double-strand breaks was
found.
Up to now, the best known complex involved in mammalian
double-strand break repair is the DNA-dependent protein kinase
(DNA-PK) complex. This complex consists of the DNA binding
subunits Ku70/80 (XRCC6/XRCC5) and the catalytic subunit
DNA-PKcs (XRCC7) and is known to be part of the
non-homologous recombination pathway, which is considered to
be the dominant dsb repair mechanism active in mammalian cells
(Jackson and Jeggo, 1995). Additionally, in primate cells, this
protein complex interacts with the Ku80-related protein KARP-1
(Myung et al, 1997). In rodent cells, any defect in this complex
was found to result in a depressed repair capacity and an enhanced
cellular radiosensitivity (Zdzienicka, 1995). However, in human
cell lines (mostly human tumour cell lines) no such correlation
was found (Allalunis-Turner et al, 1995; Nicolas et al, 1996; Lu 
et al, 1998). Up to now, there is only one human glioma cell
line known in which radiosensitivity clearly correlates with a
DNA-PKcs transcriptional defect (Lees-Miller et al, 1995).
This discrepancy between rodent and human data was the
basis of the present study, in which we wanted to investigate
whether in normal human fibroblasts the cellular radiosensitivity
and the extent of double-strand break repair also depended on
the DNA-PK complex. The study was performed with 11 normal
human fibroblast lines showing a clear difference in dsb repair
capacity that correlated with the cellular radiosensitivity
(Dikomey et al, 1999). The expression of the Ku70 and the Ku80
gene was determined by Northern blot analysis and the activity
of the DNA-PK complex was detected by the pulldown assay
(Finnie et al, 1995).
MATERIALS AND METHODS
Cell culture
The human skin fibroblast lines used were originally established
from skin biopsies of women who had received post-mastectomy
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biopsies were taken from non-irradiated areas. Fibroblasts were
grown as a monolayer in Amniomax C100 medium containing
15% supplement and fetal calf serum (7.5% each). CHO-K1 and
xrs5 cells were grown in minimal essential medium (MEM),
a-modified, containing 5% fetal calf serum (FCS). All cell
cultures were incubated at 37°C, 8% carbon dioxide and 100%
humidification. All experiments were performed with plateau
phase cultures, the human fibroblasts being in passages 6—8.
Northern blot hybridization
Total RNA was extracted according to the Fast-Prep System
(Dianova, Hamburg, Germany). Total RNA (5 mg) was run in a
1% denaturing agarose gel. Subsequently, RNA was transferred to
a nylon membrane (Hybond N+, Amersham, Braunschweig,
Germany) and was fixed by UVC cross-linking.
Nylon membranes were prehybridized for 7 h in hybridization
buffer containing 50% deionized formamide, 20% 5´ buffer
[250 mM tris-HCl pH 7.5, 1% bovine serum albumin (BSA) frac-
tion 5, 1% polyvinylpyrrolidone, 0.5% sodium pyrophosphate, 5%
sodium dodecyl sulphate (SDS), 1% Ficoll 400], 20% dextransul-
phate (50%), 1 M sodium chloride, 0.1 mg ml—1 calf thymus DNA
(ultrasound degraded, GibcoBRL, Eggenstein, Germany) at the
appropriate hybridization temperature. After addition of the heat-
denatured specific DIG-labelled probe, hybridization was carried
out overnight at the appropriate temperature (b-actin probe, 42°C;
Ku70 probe, 48°C; Ku80 probe, 42°C). After stringency washes 
(2  ´ 20 min, 2 ´ SSC + 0.1% SDS, room temperature; 2 ´ 15 min,
0.5  ´  SSC + 0.1% SDS, appropriate temperature, i.e. b-actin
probe, 47°C; Ku70 probe, 66°C; and Ku80 probe, 52°C), the
hybridization signal was detected via chemiluminescence by using
CDP-Star (Boehringer, Mannheim, Germany). Light emission was
detected either by exposure of a sensitive film (Hyperfilm ECL,
Amersham) or by direct recording and subsequent analysis
(Molecular Light Imager — Night OWL; software, winlight;
Berthold, Isernhagen, Germany).
Nylon membranes were stripped with Northern probe-stripping
solution (50% formamide, 50 mM tris-HCl pH 8, 1% SDS)
according to the Boehringer manual (Boehringer).
For the preparation of the specific DNA probes, XL1 Blue
bacteria [genotype recA1, endA1, gyrA96, thi-1, hsdR17,
supE44, relA1, lac, (F¢traD36, proAB, lacIPZ˘M15, Tn10(tet))]
were used, which were transformed with pGem-plasmid
containing the human cDNA of either the Ku70 or the Ku80
gene (p70-4z or p80-4z) and which were kindly provided by
Dr H Feldmann, Munich, Germany. Bacteria were grown in
LB-medium containing 50 mg ml—1 ampicillin. Plasmids were
isolated according to the Plasmid Maxi Kit (Qiagen, Hilden,
Germany) and were cut with the appropriate restriction enzymes
(p70-4z, EcoR1, Pst1; p80-4z, Pst1, Sma1; Pharmacia Biotech,
Freiburg, Germany). Reaction products were separated in a
1% non-denaturing agarose gel. The resulting DNA fragments
representing the specific DNA probes (Ku70, ~1000 bp; Ku80,
~400 bp) were isolated according to the QIAquick Kit (Qiagen).
These two probes were DIG-labelled by the random primed
labelling method (Boehringer). As specific b-actin probe, a 
40-base single-stranded synthetic oligonucleotide (62.5% GC
content, Oncogene Science, Dianova, Hamburg, Germany) was
used, which was DIG-labelled by the 3¢ end-labelling method
(Boehringer).
DNA-PK pulldown assay
Whole cell extracts were prepared according to Finnie et al (1995).
Trypsinized cells were washed once with phosphate-buffered
saline (140 mM Sodium chloride, 3 mM potassium chloride, 8 mM
disodium hydrogen phosphate dihydrate, 1 mM potassium
dihydrogen phosphate) and were precipitated. The cell pellet was
resuspended in one pellet volume extraction buffer (50 mM sodium
fluoride, 20 mM Hepes pH 7.6, 450 mM sodium chloride, 25%
glycerol, 0.2 mM EDTA, 0.5 mM dithiothreitol, 0.5 mM phenyl-
methylsulphonyl fluoride, 0.5 mg ml—1 leupeptin, 0.5 mg ml—1
pepstatin A protease inhibitor, 1.0 mg ml—1 soybean trypsin
inhibitor, 0.5 mg ml—1 aprotinin, 40 mg ml—1 bestatin). The suspen-
sion was frozen in liquid nitrogen and, subsequently, was thawed
at 30°C, four times each. After centrifugation at 11 000 r.p.m.
(10 min, 4°C), the supernatant (i.e. the cell extract) was stored
at —70°C. The protein concentration of this whole cell extract
was determined by the BioRad-Microassay procedure (BioRad,
Munich, Germany).
The DNA-PK activity was determined by the pulldown assay
(Finnie et al, 1995). In this assay, the DNA-PK firstly was purified
from the extract, and subsequently the enzyme activity was deter-
mined by its kinase reaction. For the purification step, calf thymus
dsDNA-cellulose (Sigma, Deisenhofen, Germany) was swollen in
buffer Z (25 mM Hepes pH 7.6, 12.5 mM magnesium chloride, 20%
glycerol, 0.1% Nonidet-P40, 1 mM dithiothreitol, 50 mM potassium
chloride) for 2—24 h at 4°C. After one washing step, the dsDNA-
cellulose pellet was resuspended in one pellet volume of buffer Z.
Twenty microlitres of this dsDNA-cellulose suspension was incu-
bated with the indicated amount of protein of the whole cell extract
for 1 h at 4°C on a rotating wheel. Thereafter, dsDNA-cellulose
was washed once with 1 ml buffer Z, and the dsDNA-cellulose
pellet was resuspended in 60 ml buffer Z. The enzyme reaction was
carried out at 30°C for 30 min and was set up as follows: 10 ml
resuspended dsDNA-cellulose, 6 ml buffer Z, 2 ml peptide (2 mM),
2 ml ATP mix; 19.5 ml dATP (2 mM, unlabelled, Amersham) with
0.5 ml [32P]ATP (>5000 Ci mmol—1, Amersham) mixed before
usage. The peptides used represent a sequence of the human p53
protein (Lees-Miller et al, 1992); specific peptide, NH2-EPPQSQE-
AFADLWKK-COOH (Eurogentec, Seraing, Belgium); mutated
peptide, NH2-EPPLSEQAFADLLKK-COOH (friendly gift of Dr J
Coco Martin, Amsterdam, The Netherlands). The enzyme reaction
was stopped by adding 30 ml acetic acid (30%). Twenty microlitres
of each sample was spotted onto a piece of phosphocellulose paper
(P81, Whatman, G￿ttingen, Germany). These P81 pieces were
washed four times with acetic acid (15%), and subsequently the
decay of incorporated 32P was counted by liquid scintillation
counting (Tri-Carb, Packard, Frankfurt a.M, Germany).
RESULTS
Gene expression of Ku70 and Ku80
The expression of the two DNA repair genes Ku70 and Ku80 was
examined in 11 different normal human fibroblast lines. The cells
were grown to confluence and the gene expression was detected
via chemiluminescence by using DIG-labelled specific DNA
probes. As demonstrated in Figure 1, each of the tested cell lines
possesses a Ku70 signal of about 2.2 kb and two variants of Ku80
transcripts of about 2.4 kb and 3.5 kb, respectively, which is in
agreement with literature (Cai et al, 1994). As a control for gel
loading, the signal intensity of b-actin was used (Figure 1C).
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gel loading using the b-actin signal. The Ku80 value represents the
sum of both transcripts. For a better comparison, all values were
normalized to the mean value. On average, the deviation from the
mean was very small, with ±9% for Ku70 and ±8% for Ku80, respec-
tively, showing that the expression of these genes is fairly constant
for the 11 cell lines. The small differences observed were considered
to result from variations in the preparation of the total RNA rather
than from biological differences in the level of gene expression
because the ranking of gene expression varied between experiments
with different RNA preparations (as indicated by the error bars).
DNA-PK activity
The activity of the DNA-PK (which represents a serine/ threonine
kinase) was determined by the pulldown assay (Finnie et al, 1995).
The specificity of this assay was tested by determination of the
32P transfer onto a specific peptide compared with the transfer onto
a mutated peptide, which lacks a DNA-PK-specific phosphoryla-
tion site, or the transfer in the absence of peptide for background
evaluation. In the presence of the specific peptide, there was a clear
kinase activity. In contrast, using the mutated peptide, the activity
detected was similar to the background level (data not shown).
These findings clearly demonstrated that the activity detected
results from the DNA-PK complex and not from other kinases.
Figure 3 represents the DNA-PK activity measured for the 11
human fibroblast lines after application of 150 mg protein of
the appropriate whole cell extract using the specific peptide. On
average, the variation was very small with a mean deviation of
±11%. The variations in the DNA-PK activity observed are in the
range of the standard errors, showing that these variations mainly
result from experimental errors but not from biologically different
levels of DNA-PK activity.
DNA-PK activity and dsb repair in normal human fibroblasts 1039
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Figure 1 Gene expression of Ku70, Ku80 and b-actin of 11 different normal
human fibroblast lines. Total RNA (5 mg) was analysed by Northern blot,
hybridization with the appropriate DIG-labelled DNA probe and subsequent
chemiluminescence detection via exposure of a light-sensitive film
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Figure 2 Relative gene expression of Ku70 and Ku80 of 11 different normal
human fibroblast lines. Data were obtained from blots like that one shown in
Figure 1, however the hybridization signals were determined directly via the
light emission recorded by a highly sensitive camera. The data were
normalized to the b-actin signal to correct for gel loading. The Ku80 value
represents the sum of both transcripts. For better comparison, all values
were normalized to the mean value. Error bars represent s.e.m. of three
independent RNA preparations
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Figure 3 Activity of DNA-PK determined for 11 normal human fibroblast
lines. Protein (150 mg) of the appropriate whole cell extract was used. All
data were corrected for the background, i.e. c.p.m. in the absence of peptide.
The error bars represent s.e.m. of two independent experiments, with
triplicate determination
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Figure 4 Relation between cellular survival, double-strand break repair
capacity and DNA-PK activity in 11 normal human fibroblast lines. (A)
Correlation between cell survival and dsb repair capacity. Cell survival after
3.5 Gy was determined for plateau phase cells by colony-forming ability, with
delayed plating (14 h) after irradiation; the repair capacity was expressed by
the number of non-repaired dsbs detected by constant field gel
electrophoresis as a fraction of DNA released from the plug 24 h after
irradiation with 100 Gy; data were taken from Dikomey et al (1999). (B) Lack
of correlation between dsb repair capacity and DNA-PK activity. The number
of non-repaired dsbs were determined as described above; data of DNA-PK
activity were taken from Figure 3Relation between DNA double-strand break repair
capacity and DNA-PK activity
The human fibroblast lines used in the present study were previ-
ously shown to differ in their cellular radiosensitivity, with the
surviving fraction measured for a dose of 3.5 Gy, SF3,5 Gy, ranging
from 0.03 to 0.28. These variations in radiosensitivity correlate
well with the double-strand break repair capacity, as demonstrated
by the number of non-repaired double-strand breaks detected 24 h
after irradiation with 100 Gy (Figure 4A). However, as demon-
strated in Figure 4B, the double-strand break repair capacity
of these fibroblast lines does not correlate with the DNA-PK
activity. Cell lines with distinct differences in the number of
non-repaired double-strand breaks did not show a variation in the
DNA-PK activity.
DISCUSSION
The knowledge of proteins defining the cellular radiosensitivity is
of profound interest in understanding the clinical phenomenon of
different, individual radiosensitivity. In the present study, it was
tested for the first time whether the cellular radiosensitivity and
double-strand break repair capacity of normal human fibroblasts is
determined by the activity of the DNA-dependent protein kinase.
This complex is known to participate to a non-homologous recom-
bination pathway, which is the dominant repair mechanism active
in mammalian cells (Jackson and Jeggo, 1995).
The experiments were carried out with confluent cultures
mainly consisting of G1 cells (>95%) to avoid cell cycle-dependent
alterations because the DNA-PK activity is known to vary with
the cell cycle with a maximum in G1 and a minimum in the S-
phase (Lee et al, 1997). In these 11 cultures, both the level of gene
expression tested for Ku70 and Ku80 and the activity of the DNA-
PK were found to show only a fairly small variation (Figure 2 and
Figure 3). On average, the deviation from the mean was less than
9% for the gene expression and 11% for the DNA-PK activity.
The 11 fibroblast lines used are known to exhibit a typical spec-
trum of normal radiosensitivity with SF3.5 Gy ranging from 0.03 to
0.28 (Dikomey et al, 1999). It was demonstrated here that the
variation in cellular radiosensitivity found for human fibroblasts
cannot be attributed to a variation in DNA-PK activity. Similar
results were previously obtained for ten human tumour cell lines
(Allalunis-Turner, 1995) and for a sensitive non-tumour cell line
(Lu et al, 1998). Only for the human glioma line MO59J could the
increase in cellular radiosensitivity be associated with a defect in
the DNA-PK complex (Lees-Miller et al, 1995).
It was also shown here that in human fibroblasts the DNA-PK
activity did not correlate with double-strand break repair capacity
(Figure 4B), although these fibroblasts were previously observed
to show a broad range in repair capacity which was found to
correlate with the respective cellular radiosensitivity (Figure 4A,
Dikomey et al, 1999). This result illustrates that in human fibro-
blasts the variation in double-strand break repair capacity cannot
result from differences in the DNA-PK activity. These results are
in contrast to data obtained for rodent cell lines of the complemen-
tation groups 5—7, for which an increase in radiosensitivity could
be ascribed to a decrease in the DNA-PK activity (Weaver, 1995).
However, these cell lines cannot be used as a general model of the
impact of the DNA-PK complex because the reduction of DNA-
PK activity was always caused by a genetic defect and not by a
variation in the transcription or translation level. Probably, an
activity of the DNA-PK other than the kinase activity is relevant
for double-strand break repair, but this activity then has to be
independent from the kinase activity.
In this context, it is also important to note that in normal human
fibroblasts the activity of DNA-PK was about 70 times higher than
in normal rodent cells (data not shown; Anderson and Lees-Miller,
1992). This difference, however, did not result in an enhanced
repair capacity of human cells (Dikomey et al, 1998). This obser-
vation indicates that the DNA-PK complex is not rate limiting for
dsb repair. Probably, other enzymes that are less expressed
compared with the DNA-PK are rate limiting and, therefore, more
relevant for double-strand break repair. From the eight genes iden-
tified so far to affect the cellular radiosensitivity of mammalian
cells (XRCC1–XRCC8), the three genes XRCC5—XRCC7 can be
excluded from determining the double-strand break repair capacity
of human fibroblast lines because of the data shown here. Also, the
XRCC1 and the XRCC3 genes can be excluded because the prod-
ucts of these genes are known to participate in single- but not in
double-strand break repair (Zdzienicka, 1995). In this respect, the
XRCC8 gene is also not relevant, because cells mutated in this
gene show normal single-strand break and double-strand break
repair (Zdzienicka, 1995). The XRCC2 gene product can also be
rejected because a defect in this gene was found only to affect the
fidelity but not the capacity of double-strand break repair
(Zdzienicka, 1995). Probably, the XRCC4 gene is of relevance. It
was recently shown that the corresponding gene product is a
stimulating factor of DNA ligase IV, acting downstream of the
Ku70/Ku80 proteins and thereby representing part of the DNA-PK
pathway (Critchlow et al, 1997; Grawunder et al, 1997; Wilson et
al, 1997). Also the ATM gene might be of importance because a
defect in this gene was found to result in a reduced double-strand
break repair capacity (Dikomey et al, 1998; Bl￿cher et al, 1991).
It should be kept in mind that cell lines defective in the DNA-
PK pathway are still able to repair more than 50% of the double-
strand breaks induced (Kemp et al, 1984; Hendrickson et al, 1991).
These double-strand breaks are repaired either by another non-
homologous recombination pathway or even by homologous
recombination, and it remains to be shown whether cellular
radiosensitivity is mainly determined by these mechanisms.
In conclusion, the data presented demonstrate that in normal
human fibroblast lines double-strand break repair capacity and
cellular radiosensitivity do not correlate with the DNA-PK
activity. Obviously, in this respect other proteins or pathways are
more relevant.
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